NCT01347177

Brief Summary

Adhesive bridges are becoming popular in patients with congenitally missing teeth and these are type of bridges that can be done with only minimal or with no preparation to replace the missing tooth/teeth. The best clinical gain is the minimal tooth preparation or no need for the removal of tooth substance. Treatment for this type of bridges does not usually require anaesthesia. In addition, adhesive bridges can provide reasonable aesthetical outcome with minimal cost and reduced chair time. The biggest issue is that high failure rate in the long term, and gray colour shining through the metal wing cemented onto the abutment tooth. This can compromise the aesthetical outcome. The aesthetical problem can be solved by the use of zirconia all ceramic material to construct the bridge.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 4, 2011

Completed
11 months until next milestone

Study Start

First participant enrolled

April 1, 2012

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

September 26, 2022

Status Verified

January 1, 2011

Enrollment Period

6 years

First QC Date

April 27, 2011

Last Update Submit

September 23, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical survival of adhesive bridges

    Evaluation of clinical survival: participants will be evaluated according to the modified USPHS criteria. The evaluation criteria will include: retention, framework fracture, veneering fracture, marginal adaptation, recurrent caries and colour match. The examination will be after one to two weeks, after 3, 6, 9, 12 and 18 months, 2, 3, 4 and 5 years. The evaluation will also include the biological complication. Plaque, gingival index, periodontal probing depth and gingival recession will be evaluated around the abutments and compared to a control tooth

    5 Years

Secondary Outcomes (3)

  • Quality of life, aesthetic outcome.

    18 months

  • Marginal discrepancy evaluation.

    After cementation

  • Economic evaluation

    5 years

Study Arms (2)

Zirconia-based adhesive bridges

EXPERIMENTAL

Patients in this group will be treated with the employment of zirconia-based adhesive bridges to replace the missing tooth/teeth.

Procedure: Zirconia-based adhesive bridge

Metal-based adhesive bridges

EXPERIMENTAL

Patients in this group will be treated with the employment of metal-based adhesive bridges.

Procedure: Metal-based adhesive bridge

Interventions

Zirconia-based adhesive bridge will be used to replace the missing tooth/teeth.

Zirconia-based adhesive bridges

The metal-based adhesive bridge will be used to replace the missing tooth/teeth.

Metal-based adhesive bridges

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥ 18 years of age
  • Has a maximum of 2 units requiring placement
  • Is a regular dental attendee and agree to return for assessments
  • Written subject informed consent (IC) for this protocol will be obtained prior to study enrolment. Each subject will be required to sign and date the IC form prior to their participation
  • Sound or minimally restored abutment(s)

You may not qualify if:

  • The presence of any periodontal pocket depths equal or above 4 mm with active periodontal disease
  • Any history of adverse reaction to clinical materials to be used in this study
  • They are pregnant or had serious medical condition that may interfere with the dental treatment
  • Acquired tooth loss more than 2 units requiring replacement
  • Participants who have parafunctional habits
  • Severe Class II Div II cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barts and The London, School of Medicine and Dentistry

London, E1 2AD, United Kingdom

Location

MeSH Terms

Conditions

Anodontia

Condition Hierarchy (Ancestors)

Tooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Aylin Baysan, BDS, MSc, PhD

    Queen Mary University of London

    PRINCIPAL INVESTIGATOR
  • Amani Agha, BDS,MSc

    Queen Mary University of London

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2011

First Posted

May 4, 2011

Study Start

April 1, 2012

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

September 26, 2022

Record last verified: 2011-01

Locations